512 related articles for article (PubMed ID: 25088942)
1. Type 3 diabetes is sporadic Alzheimer׳s disease: mini-review.
de la Monte SM
Eur Neuropsychopharmacol; 2014 Dec; 24(12):1954-60. PubMed ID: 25088942
[TBL] [Abstract][Full Text] [Related]
2. Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease.
de la Monte SM
Curr Alzheimer Res; 2012 Jan; 9(1):35-66. PubMed ID: 22329651
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of nitrosamine-mediated neurodegeneration: potential relevance to sporadic Alzheimer's disease.
de la Monte SM; Tong M
J Alzheimers Dis; 2009; 17(4):817-25. PubMed ID: 19542621
[TBL] [Abstract][Full Text] [Related]
4. Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease.
Tong M; Neusner A; Longato L; Lawton M; Wands JR; de la Monte SM
J Alzheimers Dis; 2009; 17(4):827-44. PubMed ID: 20387270
[TBL] [Abstract][Full Text] [Related]
5. Brain metabolic dysfunction at the core of Alzheimer's disease.
de la Monte SM; Tong M
Biochem Pharmacol; 2014 Apr; 88(4):548-59. PubMed ID: 24380887
[TBL] [Abstract][Full Text] [Related]
6. Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus.
Moroz N; Tong M; Longato L; Xu H; de la Monte SM
J Alzheimers Dis; 2008 Sep; 15(1):29-44. PubMed ID: 18780965
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance and Alzheimer's disease.
de la Monte SM
BMB Rep; 2009 Aug; 42(8):475-81. PubMed ID: 19712582
[TBL] [Abstract][Full Text] [Related]
8. Middle-Aged Diabetic Females and Males Present Distinct Susceptibility to Alzheimer Disease-like Pathology.
Candeias E; Duarte AI; Sebastião I; Fernandes MA; Plácido AI; Carvalho C; Correia S; Santos RX; Seiça R; Santos MS; Oliveira CR; Moreira PI
Mol Neurobiol; 2017 Oct; 54(8):6471-6489. PubMed ID: 27730513
[TBL] [Abstract][Full Text] [Related]
9. Neuropathology of type 2 diabetes: a short review on insulin-related mechanisms.
Guerrero-Berroa E; Schmeidler J; Beeri MS
Eur Neuropsychopharmacol; 2014 Dec; 24(12):1961-6. PubMed ID: 24529419
[TBL] [Abstract][Full Text] [Related]
10. The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins.
Bharadwaj P; Wijesekara N; Liyanapathirana M; Newsholme P; Ittner L; Fraser P; Verdile G
J Alzheimers Dis; 2017; 59(2):421-432. PubMed ID: 28269785
[TBL] [Abstract][Full Text] [Related]
11. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
12. Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer's Disease.
Sun Y; Ma C; Sun H; Wang H; Peng W; Zhou Z; Wang H; Pi C; Shi Y; He X
J Diabetes Res; 2020; 2020():4981814. PubMed ID: 32083135
[TBL] [Abstract][Full Text] [Related]
13. An update on potential links between type 2 diabetes mellitus and Alzheimer's disease.
De Sousa RAL; Harmer AR; Freitas DA; Mendonça VA; Lacerda ACR; Leite HR
Mol Biol Rep; 2020 Aug; 47(8):6347-6356. PubMed ID: 32740795
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance and Alzheimer's disease: molecular links & clinical implications.
Neumann KF; Rojo L; Navarrete LP; Farías G; Reyes P; Maccioni RB
Curr Alzheimer Res; 2008 Oct; 5(5):438-47. PubMed ID: 18855585
[TBL] [Abstract][Full Text] [Related]
15. Crucial players in Alzheimer's disease and diabetes mellitus: Friends or foes?
Kubis-Kubiak AM; Rorbach-Dolata A; Piwowar A
Mech Ageing Dev; 2019 Jul; 181():7-21. PubMed ID: 31085195
[TBL] [Abstract][Full Text] [Related]
16. Diabetes Mellitus Induces Alzheimer's Disease Pathology: Histopathological Evidence from Animal Models.
Kimura N
Int J Mol Sci; 2016 Apr; 17(4):503. PubMed ID: 27058526
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease.
Zhao WQ; Townsend M
Biochim Biophys Acta; 2009 May; 1792(5):482-96. PubMed ID: 19026743
[TBL] [Abstract][Full Text] [Related]
18. Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease.
Pardeshi R; Bolshette N; Gadhave K; Ahire A; Ahmed S; Cassano T; Gupta VB; Lahkar M
Psychoneuroendocrinology; 2017 Sep; 83():159-171. PubMed ID: 28624654
[TBL] [Abstract][Full Text] [Related]
19. Iron metabolism in diabetes-induced Alzheimer's disease: a focus on insulin resistance in the brain.
Chung JY; Kim HS; Song J
Biometals; 2018 Oct; 31(5):705-714. PubMed ID: 30043289
[TBL] [Abstract][Full Text] [Related]
20. Possible implications of insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis.
Bosco D; Fava A; Plastino M; Montalcini T; Pujia A
J Cell Mol Med; 2011 Sep; 15(9):1807-21. PubMed ID: 21435176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
